Incyte (INCY) Misses Q4 EPS by 7c
Incyte (NASDAQ: INCY) reported Q4 EPS of $0.40, $0.07 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $468 million versus the consensus estimate of $485.8 million.
2019 Financial Guidance
The Company has provided full year 2019 financial guidance, as detailed below.
| � | � | � | � |
| � | � | � | 2019 |
| GAAP and Non-GAAP Jakafi net product revenues | � | � | $1,580 - $1,650 million |
| GAAP and Non-GAAP Iclusig net product revenues | $90 - $100 million | ||
| � | |||
| GAAP Cost of product revenues | $112 - $117 million | ||
| Non-GAAP Cost of product revenues(1) | $90 - $95 million | ||
| � | |||
| GAAP Research and development expenses | $1,185 - $1,255 million | ||
| Non-GAAP Research and development expenses(2) | $1,030 - $1,100 million | ||
| � | |||
| GAAP Selling, general and administrative expenses | $471 - $521 million | ||
| Non-GAAP Selling, general and administrative expenses(3) | $420 - $470 million | ||
| � | |||
| GAAP Change in fair value of acquisition-related contingent consideration | $30 million | ||
| Non-GAAP Change in fair value of acquisition-related contingent consideration(4) | � | � | $0 million |
For earnings history and earnings-related data on Incyte (INCY) click here.